glp-1 semaglutide and tirzepatide is glp 1 or Tirzepatide vs. Semaglutide: Which Is Better? – New Leaf Online GLP-1 and Inflammation: How These

However, this doesnt tell the full story

In January 2025, Novo Nordisk stated that the United States Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease progression, kidney failure (end-stage renal disease), and cardiovascular disease-related death in individuals with type 2 diabetes and chronic kidney disease (CKD)

Weight loss is a secondary benefit, typically less than whats observed with GLP-1 receptor agonists

Daily liraglutide injections achieve 510% average weight loss over one year (SCALE trial)

If the color does not become uniform after gentle mixing, the formulation may have a problem

Typical Weight Loss Timeline: Initial Effects: Appetite reduction is often noticeable within the first few days or weeks of starting treatment